Clinical trial
Does Subcutaneous Granulocyte Colony Stimulating Factor (G-CSF) Improve Ovarian Reserve in Women With Premature Ovarian Insufficiency?
NCT06117982 is registered in ClinicalTrials.gov with Trio Fertility as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Does Subcutaneous Granulocyte Colony Stimulating Factor (G-CSF) Improve Ovarian Reserve in Women With Premature Ovarian Insufficiency?
- Lead sponsor
- Trio Fertility
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- October 13, 2023
- Completion date
- May 1, 2025
- Enrollment
- 11 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
premature ovarian failure, primary ovarian insufficiency